MENU
DRUG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Bright Minds Biosciences (DRUG) Ownership - Who owns Bright Minds Biosciences?
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain... Show more
Profile
Industry
N/A
Address
19 Vestry Street
Phone
+1 647 865-8622
Employees
N/A
Web
https://www.brightmindsbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
296.85M
P/E Ratio
N/A
Total Cash
51.39M
Projected Growth
N/A
Total Debt
141.03K
Revenue
N/A
Risk (Beta)
-12.59
Dividend Yield
N/A
Total Cash/Share
7.25
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
DRUG
Capitalization
297M
P/E Ratio
N/A
Risk (Beta)
-12.59
Dividend Yield
N/A
Total Cash
51.4M
Total Cash/Share
7.25
Total Debt
141K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
51.8M
P/B Ratio
8.22
Cash Flow
N/A
Earnings
-1.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
89.9M
Current Ratio
86.56
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-8.94M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-30.34
Shares Held By Institutions
181M
Shares Outstanding - Current
7.09M
Total Liabilities
668K
Total Volume MTD
N/A
Value
N/A
Gain YTD
20.378
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
19 Vestry Street
Phone
+1 647 865-8622
Employees
N/A
Web
https://www.brightmindsbio.com